Certara Executive and Leadership Team

November, 2026

Leadership Overview

Certara has 7 executives leading key functions including strategy, marketing, technology, human resources, finance, data sciences, and drug development solutions.

Focused on accelerating the drug development lifecycle through biosimulation, Certara delivers AI-driven platforms and scientific consulting to optimize clinical outcomes and streamline regulatory submissions for global pharmaceutical partners.

Leadership Roles at Certara

  • Chief Executive Officer - Jon Resnick
  • Interim Chief Financial Officer. - Faiz Mohammed
  • President, Certara Data Sciences - Martin Snyder
  • President, Certara Drug Development Solutions - Adrian McKemey
  • Chief Marketing Officer - Sheila Rocchio
  • Chief Technology Officer - Chris Bouton
  • Chief Human Resources Officer - Rona Anhalt
  • Jon Resnick - Chief Executive Officer

    Jon Resnick, the Chief Executive Officer at Certara, directs the overarching corporate strategy and long-term vision for the organization. Resnick oversees the integration of biosimulation technologies across the entire drug development lifecycle, ensuring that the company maintains a competitive edge in the global life sciences market. By aligning internal resources with the needs of pharmaceutical clients, the Chief Executive Officer drives operational excellence and sustainable growth. This leadership role involves constant engagement with the Board to refine market positioning and expand the reach of model-informed drug development platforms. Through the prioritization of innovation and scientific rigor, Jon Resnick secures the company's status as a leader in clinical trial optimization. Ultimately, Resnick fosters a culture of high performance that supports the delivery of critical therapies to patients worldwide while maintaining strong financial health and operational scalability.
    Jon Resnick

    Faiz Mohammed - Interim Chief Financial Officer.

    Faiz Mohammed, the Interim Chief Financial Officer. at Certara, directs the financial planning, reporting, and capital allocation strategies. Mohammed oversees the fiscal health of the organization, ensuring that resources are effectively deployed to support the development of AI-driven platforms and scientific consulting services. By managing the budgeting process and financial forecasting, the Interim Chief Financial Officer. provides the necessary insights to support long-term investment in drug development technologies. This leadership role involves maintaining rigorous compliance standards and ensuring transparency in all financial operations for stakeholders. Through the optimization of cost structures and revenue streams, Faiz Mohammed supports the company's growth objectives and market expansion efforts. Mohammed works closely with the executive team to evaluate the financial impact of strategic initiatives, ensuring that the company maintains a strong balance sheet while pursuing its mission to revolutionize the drug development lifecycle.

    Martin Snyder - President, Certara Data Sciences

    Martin Snyder, the President, Certara Data Sciences at Certara, directs the specialized data science division focused on advanced analytics and modeling. Snyder oversees the application of machine learning and statistical methodologies to solve complex problems within the drug development lifecycle. By leading the development of proprietary data tools, the President, Certara Data Sciences ensures that the company provides actionable insights for preclinical and clinical research. This leadership role involves managing the integration of large-scale datasets to improve the accuracy of biosimulation models. Through the coordination of cross-functional teams, Martin Snyder drives the delivery of high-value data solutions that assist clients in navigating regulatory submissions and market access. Snyder focuses on expanding the division's capabilities to address emerging challenges in the pharmaceutical industry, ensuring that the company remains a leader in data-driven decision-making and clinical outcome optimization.
    Martin Snyder

    Adrian McKemey - President, Certara Drug Development Solutions

    Adrian McKemey, the President, Certara Drug Development Solutions at Certara, directs the delivery of scientific consulting services across the entire drug development spectrum. McKemey oversees the operational execution of clinical trials and regulatory strategy projects for global pharmaceutical partners. By leveraging the company's biosimulation expertise, the President, Certara Drug Development Solutions ensures that clients receive tailored guidance to optimize drug behavior and clinical success. This leadership role involves managing the consulting teams that provide critical support from discovery through market access. Through the implementation of efficient project management frameworks, Adrian McKemey ensures that all client engagements meet the highest standards of scientific rigor and regulatory compliance. McKemey focuses on scaling the consulting business to meet the growing demand for model-informed drug development, ensuring that the organization consistently delivers value and accelerates the path to market for life-saving therapies.
    Adrian McKemey

    Sheila Rocchio - Chief Marketing Officer

    Sheila Rocchio, the Chief Marketing Officer at Certara, architects the global brand strategy and market engagement initiatives. Rocchio manages the communication of complex biosimulation value propositions to diverse stakeholders across the pharmaceutical and biotechnology sectors. Overseeing the development of targeted campaigns, the Chief Marketing Officer ensures that the company's AI-driven platforms remain top-of-mind for researchers and regulatory professionals. This leadership role requires close collaboration with product teams to translate technical advancements into compelling market narratives that drive adoption. By analyzing market trends and competitive dynamics, Sheila Rocchio optimizes the lead generation funnel and strengthens the company's presence in key international markets. Through the execution of data-backed marketing programs, Rocchio enhances brand equity and supports the expansion of the client base, ensuring that the organization effectively communicates the transformative impact of its scientific consulting services.
    Sheila Rocchio

    Chris Bouton - Chief Technology Officer

    Chris Bouton, the Chief Technology Officer at Certara, directs the development and deployment of advanced software and AI-driven platforms. Bouton oversees the engineering teams responsible for building the biosimulation tools that power the drug development lifecycle. By integrating cutting-edge computational methods, the Chief Technology Officer ensures that the company's software suite remains at the forefront of scientific innovation. This leadership role involves managing the technical roadmap and ensuring that all digital solutions meet the rigorous demands of regulatory submissions and clinical modeling. Through the continuous improvement of data processing capabilities, Chris Bouton enables faster and more accurate drug behavior predictions for global clients. Bouton maintains a focus on scalability and security, ensuring that the technological infrastructure supports the company's mission to optimize clinical outcomes. Ultimately, the Chief Technology Officer drives the digital transformation necessary to maintain a significant competitive advantage in the life sciences industry.
    Chris Bouton

    Rona Anhalt - Chief Human Resources Officer

    Rona Anhalt, the Chief Human Resources Officer at Certara, directs the global talent strategy and organizational development initiatives. Anhalt oversees the recruitment, retention, and professional growth of the scientific and technical workforce essential to the company's success. By fostering an inclusive and high-performance culture, the Chief Human Resources Officer ensures that the organization attracts top-tier talent capable of advancing biosimulation and drug development solutions. This leadership role involves designing compensation structures and performance management systems that align with the company's strategic objectives. Through the implementation of comprehensive training programs, Rona Anhalt supports the continuous development of the staff, ensuring that the team remains equipped to handle complex regulatory and clinical challenges. Anhalt manages the human capital requirements across all international operations, ensuring that the workforce remains agile and focused on the company's mission to improve patient outcomes through scientific excellence.
    Rona Anhalt

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Certara Top Executives and Leadership Team

    Who leads Certara?
    Certara is led by Jon Resnick (Chief Executive Officer), along with executives such as Faiz Mohammed (Interim Chief Financial Officer.) and Martin Snyder (President, Certara Data Sciences).
    Who is part of Certara’s executive team?
    The executive team of Certara includes leaders such as Jon Resnick (Chief Executive Officer), Faiz Mohammed (Interim Chief Financial Officer.), Martin Snyder (President, Certara Data Sciences) and other senior executives.
    How many executives does Certara have?
    Certara has 7 executives leading key business areas.
    What roles are included in Certara’s leadership team?
    The leadership team of Certara includes roles such as Chief Executive Officer, Interim Chief Financial Officer., President, Certara Data Sciences, President, Certara Drug Development Solutions, Chief Marketing Officer.